172 related articles for article (PubMed ID: 24714586)
1. In depth analysis on the binding sites of adamantane derivatives in HCV (hepatitis C virus) p7 channel based on the NMR structure.
Du QS; Wang SQ; Chen D; Meng JZ; Huang RB
PLoS One; 2014; 9(4):e93613. PubMed ID: 24714586
[TBL] [Abstract][Full Text] [Related]
2. Unusual architecture of the p7 channel from hepatitis C virus.
OuYang B; Xie S; Berardi MJ; Zhao X; Dev J; Yu W; Sun B; Chou JJ
Nature; 2013 Jun; 498(7455):521-5. PubMed ID: 23739335
[TBL] [Abstract][Full Text] [Related]
3. Computational Study of HCV p7 Channel: Insight into a New Strategy for HCV Inhibitor Design.
Ying B; Pang S; Yang J; Zhong Y; Wang J
Interdiscip Sci; 2019 Jun; 11(2):292-299. PubMed ID: 30194627
[TBL] [Abstract][Full Text] [Related]
4. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP
Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015
[TBL] [Abstract][Full Text] [Related]
5. Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.
Mathew S; Fatima K; Fatmi MQ; Archunan G; Ilyas M; Begum N; Azhar E; Damanhouri G; Qadri I
PLoS One; 2015; 10(6):e0126510. PubMed ID: 26030803
[TBL] [Abstract][Full Text] [Related]
6. Understanding the inhibitory mechanism of BIT225 drug against p7 viroporin using computational study.
Behmard E; Abdolmaleki P; Taghdir M
Biophys Chem; 2018 Feb; 233():47-54. PubMed ID: 29169687
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor Development against p7 Channel in Hepatitis C Virus.
Wei S; Hu X; Du L; Zhao L; Xue H; Liu C; Chou JJ; Zhong J; Tong Y; Wang S; OuYang B
Molecules; 2021 Mar; 26(5):. PubMed ID: 33802584
[TBL] [Abstract][Full Text] [Related]
8. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
Foster TL; Verow M; Wozniak AL; Bentham MJ; Thompson J; Atkins E; Weinman SA; Fishwick C; Foster R; Harris M; Griffin S
Hepatology; 2011 Jul; 54(1):79-90. PubMed ID: 21520195
[TBL] [Abstract][Full Text] [Related]
9. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
[TBL] [Abstract][Full Text] [Related]
10. Transverse relaxation dispersion of the p7 membrane channel from hepatitis C virus reveals conformational breathing.
Dev J; Brüschweiler S; Ouyang B; Chou JJ
J Biomol NMR; 2015 Apr; 61(3-4):369-78. PubMed ID: 25724842
[TBL] [Abstract][Full Text] [Related]
11. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
Du QS; Huang RB; Wang SQ; Chou KC
PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
[TBL] [Abstract][Full Text] [Related]
12. NMR structure and ion channel activity of the p7 protein from hepatitis C virus.
Montserret R; Saint N; Vanbelle C; Salvay AG; Simorre JP; Ebel C; Sapay N; Renisio JG; Böckmann A; Steinmann E; Pietschmann T; Dubuisson J; Chipot C; Penin F
J Biol Chem; 2010 Oct; 285(41):31446-61. PubMed ID: 20667830
[TBL] [Abstract][Full Text] [Related]
13. Exploring Strong Interactions in Proteins with Quantum Chemistry and Examples of Their Applications in Drug Design.
Xie NZ; Du QS; Li JX; Huang RB
PLoS One; 2015; 10(9):e0137113. PubMed ID: 26339784
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target.
Khaliq S; Jahan S; Hassan S
Liver Int; 2011 May; 31(5):606-17. PubMed ID: 21457434
[TBL] [Abstract][Full Text] [Related]
15. "Too little, too late?" Will inhibitors of the hepatitis C virus p7 ion channel ever be used in the clinic?
Griffin S
Future Med Chem; 2014; 6(17):1893-907. PubMed ID: 25495983
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional structure and interaction studies of hepatitis C virus p7 in 1,2-dihexanoyl-sn-glycero-3-phosphocholine by solution nuclear magnetic resonance.
Cook GA; Dawson LA; Tian Y; Opella SJ
Biochemistry; 2013 Aug; 52(31):5295-303. PubMed ID: 23841474
[TBL] [Abstract][Full Text] [Related]
17. Interaction of antivirals with a heptameric bundle model of the p7 protein of hepatitis C virus.
Dahl SL; Kalita MM; Fischer WB
Chem Biol Drug Des; 2018 Apr; 91(4):942-950. PubMed ID: 29251816
[TBL] [Abstract][Full Text] [Related]
18. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria.
Griffin SDC; Harvey R; Clarke DS; Barclay WS; Harris M; Rowlands DJ
J Gen Virol; 2004 Feb; 85(Pt 2):451-461. PubMed ID: 14769903
[TBL] [Abstract][Full Text] [Related]
19. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
Griffin S; Stgelais C; Owsianka AM; Patel AH; Rowlands D; Harris M
Hepatology; 2008 Dec; 48(6):1779-90. PubMed ID: 18828153
[TBL] [Abstract][Full Text] [Related]
20. A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro.
Hong W; Lang Y; Li T; Zeng Z; Song Y; Wu Y; Li W; Cao Z
J Biol Chem; 2015 Sep; 290(38):23254-63. PubMed ID: 26251517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
